Search

Search Constraints

You searched for: Author/Creator Segal, A

Search Results

3. P313 Within, 6 months from COVID-19 BNT162b2 vaccine patients with Inflammatory Bowel Diseases treated with Anti-TNFα have significantly lower serologic responses. (21st January 2022)

4. P640 Serologic response and safety after third dose of the COVID-19 BNT162b2 vaccine in patients with Inflammatory Bowel Diseases. (30th January 2023)